Biologics Market Size, Share, Trends & Forecast
The Biologics Market is expanding rapidly as healthcare systems increasingly adopt targeted biological therapies for complex and chronic diseases. Market Research Future values the global market at USD 616.25 billion in 2024 and projects it to reach USD 3,338.29 billion by 2035, representing a CAGR of 16.6% during 2025–2035.
Biologics include monoclonal antibodies, vaccines, recombinant proteins, hormones, and cell and gene therapies. Their ability to target specific biological pathways is increasing their importance in oncology, autoimmune disorders, infectious diseases, cardiovascular conditions, and neurological disorders.
Growing investment in biotechnology and personalized medicine is supporting innovation across the sector. Pharmaceutical companies are also expanding biologics pipelines as demand for more precise treatment options increases.